Welcome to
The Best of ObesityWeek®
Your selection of highlights and key takeaways from ObesityWeek®.
Presidents' Wrap Up
Faculty Interviews
“BMI is just a screener, it doesn’t tell us what the patient’s health status is”
- Donna Ryan
“This is a first for patients who don’t have T2D—to be able to show that we can actually prevent heart attack, stroke, and sudden cardiovascular death—so it’s a really big deal.”
- Donna Ryan
“It’s a call to action for physicians—let’s identify patients who would benefit from the SELECT findings.”
- Donna Ryan
“We have multiple buckets of innovation today that are going to change the landscape”
- Daniel J. Drucker
“The reduction in calories turns on a lot of maintenance and repair systems and cells, which is good for cellular health”
- Stephen Kritchevsky
“This is a 3-year study … the longest-term duration for a dual agonist.”
- Sean Wharton
“You are going to get GI side effects … everybody needs to know what is going to happen, that expectation is a really big part”
- Sean Wharton
“The greatest, most impressive result I’ve ever seen in the progression from pre-diabetes to full diabete”
- Louis Aronne
“We have such effective drugs that, in many cases, we're seeing we have to stop people from losing weight”
- Louis Aronne
“The brain and the microbiome are BFFs; you can’t separate the two”
- Arpana Church
“Trauma-informed obesity care does not just address physical health—it addresses the whole person.”
- Robyn Pashby
“Waist-to-height ratio is a better predictor of the presence or absence of cardiovascular disease than BMI, which really doesn’t predict it.”
- Louis Aronne
“One of the good things about SELECT was the 4 years of observation in a really diverse, large population.”
- Donna Ryan
“It’s not just about heart attack and stroke; it’s improvement in heart failure, it’s improvement in chronic kidney disease.”
- Donna Ryan
Testimonials
Ask the Expert